Dell Technologies vs. UiPath: Which Technology Stock Is a Better Buy in 2026?

The article contrasts Dell vs. UiPath for 2026, citing Dell FY2026 revenue near $113.5B (+~19% YoY), net income >$5.9B, and free cash flow of ~$8.6B, alongside higher leverage (debt-to-equity ~-12.8x) and a weak current ratio (~0.9x). UiPath FY2026 revenue was ~$1.6B (+~12.7%), net income ~$282.3M (net margin ~17.5% vs prior-year loss), stronger liquidity (current ratio ~2.5x) and no meaningful debt (debt-to-equity ~0.0x), but with high customer concentration and high SBC drag on operating cash flow (~78.3%). Valuation shows Dell at a higher P/S (2.2x) but lower forward P/E (23.6x) than UiPath (forward P/E 20.8x, P/S 5.4x), while near-term views for UiPath include FQ FY2027 revenue beat (sales >10% to $1.78B full-year outlook). Overall, the piece is investment-leaning on AI tailwinds but flags meaningful balance-sheet, customer concentration, and competitive/cyber/regulatory risks.

Analysis

The cleaner near-term winner is the AI infrastructure stack, but not equally across the chain. Dell’s leverage to server demand is real, yet the market should treat it as a working-capital and supply-chain trade first, not a pure margin expansion story; if deployments slow even modestly, inventory and receivables can swing cash conversion quickly. Upstream beneficiaries with better pricing power remain NVDA and, to a lesser extent, memory/optics vendors; Dell is more of a pass-through of capex than a durable toll booth.

UiPath’s profitability inflection is more fragile than it looks because the quality of cash generation is diluted by equity compensation and customer concentration. That means the stock can rerate only if management proves that new automation spend is becoming embedded, not merely experimental; otherwise, Microsoft and Amazon can bundle similar functionality into broader platforms and cap standalone pricing power. On a 1-3 month horizon, the market is likely to reward sequential growth beats, but over 6-18 months the key question is whether PATH can reduce dilution faster than it can grow revenue.

Contrarian view: consensus may be underestimating how much of Dell’s upside is already tied to a small set of buyers, making the name more exposed to capex pauses than the AI narrative suggests. Conversely, PATH may be over-discounted if consumption pricing and cross-sell work, but the burden of proof is high. The thesis is falsified if Dell’s AI-related backlog stops converting to FCF or if PATH’s SBC remains structurally elevated while enterprise expansion stalls.

Key Decisions for Investors

• Initiate a relative-value pair: long DELL / short PATH for 1-3 months, sized modestly, on the view that Dell has the more visible near-term monetization of AI capex while PATH’s ‘profitability’ is still quality-controversial; cover if PATH shows sustained operating leverage without SBC creep.
• Use NVDA as the cleaner way to express the AI infrastructure cycle rather than DELL if the goal is exposure to hardware demand with less customer-concentration risk; DELL is more of a second-order beneficiary with higher balance-sheet and execution risk.
• If already long PATH, sell upside into any post-earnings pop unless management gives explicit guidance that SBC as a % of operating cash flow is falling meaningfully over the next 2 quarters.
• Watch MSFT and AMZN as competitive pressure indicators for PATH; if either expands automation bundling or pricing concessions, PATH’s multiple is vulnerable even on decent revenue growth.